📰 Abt News
Page 67 - Abt News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Abt. Real-time updates on events, politics, business and more.
November 22, 2023
Capital International Inc. CA increased its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 12.3% in the 2nd quarter, according to its most recent 13F filing with the SEC. The firm owned 342,668 shares of the healthcare product maker’s stock after buying an additional 37,516 shares during the period. Capital International Inc. CA’s holdings […]
November 22, 2023
Sei Investments Co. lowered its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 5.0% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 773,553 shares of the healthcare product maker’s stock after selling 40,849 shares during the quarter. Sei Investments […]
November 21, 2023
Capasso Planning Partners LLC grew its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 10.5% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 4,365 shares of the healthcare product maker’s stock after purchasing an additional 416 shares during the period. Capasso […]
November 19, 2023
Great West Life Assurance Co. Can lessened its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 1.8% during the 2nd quarter, HoldingsChannel reports. The firm owned 1,364,732 shares of the healthcare product maker’s stock after selling 25,414 shares during the period. Great West Life Assurance Co. Can’s holdings in Abbott Laboratories were […]
November 19, 2023
Arcblock (ABT) traded down 4.2% against the U.S. dollar during the 24-hour period ending at 16:00 PM Eastern on November 19th. Arcblock has a market cap of $8.91 million and approximately $99,294.76 worth of Arcblock was traded on exchanges in the last 24 hours. One Arcblock token can currently be purchased for approximately $0.0904 or […]
November 18, 2023
Shelton Capital Management trimmed its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 12.4% during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 47,048 shares of the healthcare product maker’s stock after selling 6,648 shares during the quarter. Shelton Capital Management’s holdings […]
November 18, 2023
Legacy Capital Group California Inc. raised its position in Abbott Laboratories (NYSE:ABT – Free Report) by 2.4% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 6,791 shares of the healthcare product maker’s stock after acquiring an additional 162 shares during the […]
November 17, 2023
Great Lakes Advisors LLC reduced its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 1.8% during the 2nd quarter, HoldingsChannel reports. The institutional investor owned 1,023,243 shares of the healthcare product maker’s stock after selling 19,117 shares during the quarter. Abbott Laboratories comprises 1.1% of Great Lakes Advisors LLC’s portfolio, making the […]
November 17, 2023
Trillium Asset Management LLC boosted its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 3.5% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 9,436 shares of the healthcare product maker’s stock after buying an additional 316 shares during […]
November 17, 2023
Evolutionary Tree Capital Management LLC acquired a new position in shares of Abbott Laboratories (NYSE:ABT – Free Report) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 12,055 shares of the healthcare product maker’s stock, valued at approximately $1,314,000. […]